HomeCompareRYT vs JNJ

RYT vs JNJ: Dividend Comparison 2026

RYT yields 0.41% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RYT wins by $229.00 in total portfolio value
10 years
RYT
RYT
● Live price
0.41%
Share price
$41.18
Annual div
$0.17
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.3K
Annual income
$42.52
Full RYT calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — RYT vs JNJ

📍 RYT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRYTJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RYT + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RYT pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RYT
Annual income on $10K today (after 15% tax)
$35.18/yr
After 10yr DRIP, annual income (after tax)
$36.14/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $667.47/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RYT + JNJ for your $10,000?

RYT: 50%JNJ: 50%
100% JNJ50/50100% RYT
Portfolio after 10yr
$20.1K
Annual income
$435.15/yr
Blended yield
2.16%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

RYT
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RYT buys
0
JNJ buys
0
No recent congressional trades found for RYT or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRYTJNJ
Forward yield0.41%3.36%
Annual dividend / share$0.17$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$20.3K$20.0K
Annual income after 10y$42.52$827.78
Total dividends collected$420.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RYT vs JNJ ($10,000, DRIP)

YearRYT PortfolioRYT Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,741$41.39$10,676$355.77+$65.00RYT
2$11,535$41.55$11,407$389.39+$128.00RYT
3$12,384$41.70$12,198$426.53+$186.00RYT
4$13,293$41.85$13,056$467.62+$237.00RYT
5$14,265$41.98$13,987$513.12+$278.00RYT
6$15,306$42.10$14,998$563.56+$308.00RYT
7$16,419$42.22$16,098$619.52+$321.00RYT
8$17,611$42.33$17,295$681.69+$316.00RYT
9$18,886$42.43$18,599$750.82+$287.00RYT
10$20,251$42.52$20,022$827.78+$229.00RYT

RYT vs JNJ: Complete Analysis 2026

RYTStock

The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of all of the components of the S&P 500® Information Technology Index, an index that contains the common stocks of all companies included in the S&P 500® Index that are classified as members of the information technology services sector, as defined according to the Global Industry Classification Standard (GICS).

Full RYT Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this RYT vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RYT vs SCHDRYT vs JEPIRYT vs ORYT vs KORYT vs MAINRYT vs ABBVRYT vs MRKRYT vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.